Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

BioNTech, CureVac, Valeo Pharma - the license to print money

Those who solve problems or create desires can usually earn a lot of money. One of the most important requirements is that the solution is scalable and can be sold in large quantities. The solutions around the Corona pandemic are a particularly lucrative business, because ther...
Mario Hose | August 24, 2020 |

Firm Acquires Stake in Innovative 5G Tech Company

Technical analyst Clive Maund profiles a company has taken a stake in a company that has 5G technology that eliminates the need for costly fiber optic cable infrastructure. Many of you are probably already aware that 5G is about to become one of the next Big Things, and...
Streetwise Reports | April 16, 2019 |

5 Small-Caps on Fund Manager Steve Palmer's Radar Screen

Streetwise Reports: Steve, would you give us an overview of the AlphaNorth Capital Conference? Steve Palmer: We held our 6th conference in Nassau, Bahamas, in January; it's focused on small-cap non-resource companies. This past year we had a lot of technology and ca...
Streetwise Reports | March 20, 2019 |

Cannabis testing: the new frontier

The legalization of cannabis in Canada was heralded by growers, dispensaries and users throughout the country, some of whom had been calling for an end to the prohibition of cannabis for years. What many had not anticipated was the need for a rigorous system for tes...
Richard (Rick) Mills | March 12, 2019 |

FDA Approval of Antibiotic for Bacterial Pneumonia Expected in Late Summer

An update on this biopharma's two lead drug candidate programs was provided in an H.C. Wainwright report. In a May 13 research note, H.C. Wainwright & Co. analyst Ed Arce reported that for Nabriva Therapeutics Plc (NBRV:NASDAQ) , "all eyes [are] on [its] Au...
Streetwise Reports | May 16, 2019 |

$7.5 Million Debt Conversion Clears Path for Major Upside

Hot on the heels of Torchlight Energy Resources discovering a new oil field in Texas, debt holders have elected to convert to Working Interest. Torchlight Orogrande drilling Torchlight Energy Resources Inc. (TRCH:NASDAQ) , a dynamic junior oi...
Streetwise Reports | March 11, 2020 |

Central Banks Fire Bazooka at Coronavirus. Will Gold Rally?

The new coronavirus has already infected the global economy. The global lockdown means that recession is inevitable. The central banks all over the world have stepped in, including the Fed, cutting interest rates and pumping liquidity into the system. We invite you thus ...
Arkadiusz Sieron | April 20, 2020 |

Energous Shares Charge 200% Higher After Receiving FCC Certification for Wireless Charging ...

Energous Shares Charge 200% Higher After Receiving FCC Certification for Wireless Charging Technology Shares of Energous Corp. skyrocketed after the company reported that it received certification from the FCC for its new, "groundbreaking" over-the-air, power-at-...
Streetwise Reports | April 22, 2020 |

Allogene Therapeutics Shares Climb 30% on Phase 1 Relapsed/Refractory NHL Study Data

Shares of Allogene Therapeutics traded higher and reached a new 52-week high price after the company reported initial results from its Phase 1 relapsed/refractory non-Hodgkin lymphoma trial. Clinical-stage biotechnology company Allogene Therapeutics Inc. (ALLO:NAS...
Streetwise Reports | May 15, 2020 |

Prospera Energy plots success with proven reserves, M&A plans

The following is a transcription of the above video, and The Market Online has edited it for clarity . Prospera Energy Inc. (TSXV:PEI) is a Western Canadian resource company specializing in development and production of crude oil and natural gas. Prospera is primar...
Coreena Robertson | March 27, 2024 |
1 2